In the pursuit of India 2029—a vision encompassing prosperity, progress, and inclusivity—the trajectory of the nation’s pharmaceutical and healthcare sector in the next five years holds profound significance. This period not only has implications for India but also resonates on the global pharmaceutical stage—with our status as the ‘pharmacy of the world’. Our steps forward, therefore, must be taken with the great responsibility we bear.
It is crucial to recognise the dynamic nature of the industry, driven by a diverse range of players, fostering innovation amidst shifting consumer preferences and a rapidly changing healthcare landscape. Aligned with the macroeconomic growth trends and healthcare imperatives, the pharma industry is heading towards an ambition of $130 billion by 2030. This journey will unfold against the backdrop of three pivotal themes—transformative innovation, accelerated shift towards preventive healthcare and pursuit of sustainable and equitable healthcare.
Upping the innovation quotient
For over two decades, the focus has been steadfast on developing generic medicines, propelling India to the forefront, contributing a significant 20 percent to the global generics supply by volume. As competitiveness in the generics market grows, the less crowded complex generics space is becoming a playground for pharma companies and academia. However, the future of therapy and the way we see healthcare will also be influenced by advancements in biology.
Diese Geschichte stammt aus der February 18, 2024-Ausgabe von Business Today India.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der February 18, 2024-Ausgabe von Business Today India.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Pension Scheme - Safety Net
The move to introduce the UPS has evoked mixed reactions. Analysts believe its funding will have limited impact on the fiscal math
The Reit Choice?
Real Estate Investment Trusts (Reits) Are Gaining Traction As Interest Rates Stabilise. But Returns Could Be Affected By Adverse Economic Conditions And Market Volatility
CORPORATE - Calling to Account
The sudden exit of Byju's auditor BDO marks the latest in a long series of setbacks for the edtech firm
EMPLOYMENT: Skills Push
The skill development ministry plans to partner with the UGC to improve the employability of undergraduates
Building on a Vision
L&T'S CHAIRMAN EMERITUS A. M. NAIK HAS BUILT A MAMMOTH ENTERPRISE THAT IS BUILDING A NEW INDIA, FROM ITS METRO RAIL SYSTEMS TO THE RAM TEMPLE
"KYS more important than KYC"
Vijay Kedia is a renowned equity investor; the value of his listed portfolio stands at around ₹1,750 crore
ROXX STAR
THE THAR ROXX COMBINES LUXURY WITH PERFORMANCE TO MAKE A STRONG STATEMENT IN THE MID-SIZE SUV SEGMENT
HIT THE GROUND RUNNING
Smartwatches have become indispensable tools for runners, offering real-time insights into pace, distance, heart rate, and more. Here are a few you can consider
TURNING THE TABLES
INDIA'S FURNITURE MARKET IS POISED FOR A GLOBAL TAKE-OFF. ALREADY, A HOST OF GLOBAL BRANDS HAVE MADE THE COUNTRY THEIR HOME, BUT INDIAN COMPANIES ARE NOT TOO FAR BEHIND
THE EVOLUTION OF ATHERA
IDENTIFYING OPPORTUNITIES IN ADVANCE HAS STOOD THIS BENGALURU-BASED VC FUND IN GOOD STEAD. NOW, WITH A HEIGHTENED FOCUS ON TECHNOLOGY, IT WANTS TO SUSTAIN THE SUCCESS